Rausch, Johanna; Lopez, Pamela Aranda; Bialojan, Ariane et al.
Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunizationJOURNAL OF DERMATOLOGICAL SCIENCE. Bd. 87. H. 3. 2017 S. 300-306
Paterka, Magdalena; Voss, Jan Oliver; Werr, Johannes et al.
Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitisJOURNAL OF AUTOIMMUNITY. Bd. 76. 2017 S. 108-114
Schmitt, Edgar; Bopp, Tobias
Discovery and initial characterization of Th9 cells: the early yearsSEMINARS IN IMMUNOPATHOLOGY. Bd. 39. H. 1. 2017 S. 5-10
Koenig, Patrick; Buescher, Nicoie; Steingruber, Mirjam et al.
Dynamic regulatory interaction between cytomegalovirus major tegument protein pp65 and protein kinase pUL97 in intracellular compartments, dense bodies and virionsJOURNAL OF GENERAL VIROLOGY. Bd. 98. H. 11. 2017 S. 2850-2863
Sielaff, Malte; Kuharev, Joerg; Bohn, Toszka et al.
Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram RangeJOURNAL OF PROTEOME RESEARCH. Bd. 16. H. 11. 2017 S. 4060-4072
Koenig, A.; Vaeth, M.; Mueller, G. et al.
Follicular regulatory T cells control humoral autoimmunity when NFATc1 overcomes Blimp1-mediated CXCR5 suppressionEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 47. 2017 S. 281-281
Lacher, Sonja M.; Bruttger, Julia; Kalt, Bettina et al.
HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survivalCELL DEATH & DISEASE. Bd. 8. 2017
Scheibe, Kristina; Backert, Ingo; Wirtz, Stefan et al.
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivoGUT. Bd. 66. H. 5. 2017 S. 823-838
Stergiou, Natascha; Glaffig, Markus; Jonuleit, Helmut et al.
Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic MiceCHEMMEDCHEM. Bd. 12. H. 17. 2017 S. 1424-1428
Glaffig, Markus; Stergiou, Natascha; Schmitt, Edgar et al.
Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating AdjuvantCHEMMEDCHEM. Bd. 12. H. 10. 2017 S. 722-727